
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1067 | 1064 | 1004 | 1102 | 1429 | 1729 |
Fund Return | 6.72% | 6.37% | 0.41% | 3.28% | 7.4% | 5.63% |
Place in category | 247 | 219 | 420 | 374 | 211 | 144 |
% in Category | 48 | 42 | 81 | 82 | 60 | 61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Income and Growth P EUR | 50.94B | 0.83 | 7.60 | 7.97 | ||
AllianzIncome Growth RM H2EUR | 50.94B | 0.22 | 2.57 | - | ||
AllianzIncome Growth AM H2EUR | 50.94B | 0.18 | 2.10 | 4.47 | ||
AllianzIncome Growth P H2EUR | 50.94B | 0.28 | 2.63 | 5.10 | ||
AllianzIncome Growth A H2EUR | 50.94B | 0.19 | 2.08 | 4.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth A EUR | 2.95B | 6.71 | 3.28 | 5.63 | ||
Allianz Europe Equity Growth P EUR | 2.95B | 6.87 | 4.16 | 6.53 | ||
Allianz Europe Equity Growth I EUR | 2.95B | 6.87 | 4.20 | 6.57 | ||
Allianz Europe Equity Growth PT EUR | 2.95B | 6.87 | 4.16 | 6.53 | ||
Allianz Europe Equity Growth IT EUR | 2.95B | 6.87 | 4.20 | 6.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 7.80 | 642.50 | -2.24% | |
SAP | DE0007164600 | 5.64 | 249.250 | -0.34% | |
Novo Nordisk B | DK0062498333 | 5.09 | 480.6 | -3.84% | |
DSV | DK0060079531 | 3.99 | 1,348.0 | -1.53% | |
Partners Group | CH0024608827 | 3.76 | 1,310.50 | -1.28% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review